Operating area

Business Innovation

Business Innovation includes the Orthopaedics, Genomics IT and Medical Education business units as well as Sectra’s research department. Business Innovation also manages and develops Sectra’s patent portfolio.

Quick facts

  • 43 employees
  • SEK 90 million in revenue

Figures refers to fiscal year 2023/2024.

The Group incubator

Business Innovation is the Group’s primary incubator. This includes business units, research operations and future projects that, in their current phases, can benefit from being pursued in an incubator environment or that do not easily fit into any of our existing operating areas. The latter may be because the products and services are intended for a customer segment that we are not currently targeting. In Business Innovation, there are currently only medical technology projects and operations, but this may be expanded to include projects in other areas in the future.

The long-term ambitions for Business Innovation are to:

  • contribute to better care for patients by solving difficult and important problems encountered by Sectra’s customers
  • commercialize new technology, validate clinical benefits or pursue projects that could lead to new and innovative solutions that add value for customers in Sectra’s niche areas
  • give smaller operations and business units the best conditions to develop and grow
  • build and manage a strong patent portfolio in Sectra’s key areas
  • develop business models for new products and services

The research department’s roles are to support Sectra’s established areas and to evaluate and conduct long-term, high-risk projects that can result in business within three to ten years.

Some projects soar while others fade away

Sound scientific and medical evidence is essential in healthcare. Implementing new technologies and methods is often a protracted process and associated with high risk. As a result, some research and other early-phase projects will never grow to any major degree.

In some cases, the operations in Business Innovation are already profitable with existing customers, but they need to grow further. In the long term, the business units and projects are to be managed in one of the following ways:

  • become a separate operating area
  • incorporate the unit into an existing operating area. This occurred, for example, when digital pathology was transferred to Imaging IT Solutions in 2014, due to the major synergies identified
  • discontinue if the unit does not offer sufficient potential. This occurred, for example, with the osteoporosis business unit in 2017/2018
  • spin off as an independent company or be sold to an external party if this proves to be the best solution from a financial standpoint. This occurred, for example, with the business unit for low-dose mammography products, which was divested in 2011 and the sale of patents in 2015.

Business units

Safer surgery using digital planning

Joint replacement surgery is by far the largest segment within orthopaedics and is responsible for more than one-third of all revenue in the orthopaedics market. The segment is also expected to rise sharply due to the aging population. In addition, several million surgeries are performed globally every year due to fractures caused by accidents, falls and activity-related injuries. To meet the growing need for better, more efficient care related to these kinds of surgical procedures, Sectra offers IT systems for image-based planning and follow-up of orthopaedic surgery.

For healthcare providers, increased precision in diagnosis, planning and monitoring leads to reduced costs, since the operating time is shortened while the number of implants to be prepared before every surgery is reduced. For the patient, shorter operating times reduce the risk of postoperative infections and other complications. An accurate diagnosis before surgery also reduces the risk of unnecessary and risky surgery, such as revision surgery in the case of a suspected loose implant.

Sectra’s orthopaedics offering also includes tools that improve and simplify work for radiologists who specialize in the musculoskeletal system (musculoskeletal radiology). These tools allow radiologists to perform otherwise difficult and time-consuming measurements more quickly and efficiently. In addition, the ability for orthopaedic surgeons and radiologists to work together in the same system also saves additional time, with faster diagnoses as a result.

Furthermore, our solutions also contribute to simplifying and streamlining the proof-of-concept process for new implants. Sectra’s service now makes it possible to use computer tomography to measure movement between the implant and bone in an entirely new way. Scientists and implant manufacturers are thus able to increase the quality and long-term survival rates of new implants, which is of the utmost importance for patient security.

The way forward

The business unit’s ambition is to contribute to improved orthopaedic preoperative planning and postoperative follow-up through the development and sale of services and software for image-based orthopaedic planning and follow-up. This is how we can help our customers provide better, more cost-efficient care to patients.

Prioritized activities:

  • primarily growing in those parts of Europe and North America where the business unit has an in-house sales organization and where Sectra already has an established customer base
  • sales to larger customers with a significant orthopaedic department, who thus have a need for our entire product portfolio
  • ongoing development of our musculoskeletal radiology offering
  • gathering evidence and disseminating knowledge of our products and services via clinical studies.

Customers and sales channels

The business unit’s customers are private and public orthopaedic clinics as well as manufacturers of prosthetics and implants. Sales take place through an in-house sales organization, distribution partners and as part of Sectra Imaging IT Solutions’ customer offerings.

Market position

Sectra is currently the market leader in preoperative planning of orthopaedic procedures in Scandinavia. We also command a strong market position in several other countries, including the Netherlands and the UK, and have a growing customer base in the US.

Cloud-based training platforms for reality-based learning

T he need for care is increasing constantly in parallel with a labor shortage. Managing these challenges requires new ways of working, digital tools and increased investments in the type of services that Sectra offers in medical education. Sectra Education Portal is a cloud-based service that offers reality-based learning using authentic patient cases and advanced digital tools.

Using the education portal makes it possible to base the user’s understanding on real clinical scenarios and diagnostic tools. This makes learning more efficient, from basic knowledge for students to advanced professional development for specialists and other qualified healthcare personnel. T he cloud service gives the user full control over their own learning, since it is available at any time or location—at the hospital, university or at home.

In addition to Sectra Education Portal, Sectra offers a visualization table9 that is adapted to training in the classroom or lecture hall.

The way forward

Our ambition is to help our customers to improve and streamline medical education by facilitating lifelong learning and skills development for healthcare personnel.

Prioritized activities:

  • continuing to expand existing customers’ usage in order to help them maximize the value of the portal
  • increasing sales and the number of subscribers, focusing primarily on Europe and North America
  • developing our education portal to enable increasing usage
  • strengthening synergies and increasing sales to the existing customer base within the Imaging IT Solutions operating area.

Customers and sales channels

The business unit’s customers are educational institutions and hospitals offering basic and specialist medical or veterinary studies, either privately or publicly. Sales mainly take place through an international network of distribution partners. Sales may also take place as part of Sectra Imaging IT Solutions’ customer offerings in certain markets, or directly to customers in selected countries such as Sweden.

Market position

Sectra’s cloud-based education portal with advanced visualization tools that is used in medical diagnostics, combined with a broad library of authentic patient cases, is a unique offering for medical learning at all levels. Our customers can be found in more than 50 countries, and include many of the world’s leading educational institutions and hospitals.

New initiative adds value to personalized medicine and cancer care

Each patient is unique, and customizing healthcare to each individual patient’s need is essential for the patient outcomes. Personalized medicine, also referred to as precision medicine, is the emerging practice of medicine that uses an individual’s genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease. This new practice is especially well developed within cancer care. By leveraging all patient data, from radiology, pathology and finally genomics, the most advantageous cancer treatment path is chosen for each individual patient.

Due to its essential role in treatment, genomics is one of the fastest growing fields within diagnostics. To efficiently provide precision diagnostics, close collaboration between multiple medical specialties is needed to support these new diagnostic workflows. In collaboration with healthcare providers in the US and Sweden, Sectra is driving innovative product development in this field to further increase the value provided to customers. By combining medical imaging IT for radiology and pathology with IT support for Genomics, we are helping to develop the diagnostics of the future.

This new area of diagnostic IT tools is being developed within the Genomics IT business unit, which was started in 2022. The ongoing development project spans several years and is off to a good start. Together with one of the most prominent cancer healthcare providers in the US, we put the first version of the system into clinical operation in spring 2024. The situation is similar to when the digital pathology product was launched as an expansion of Sectra’s radiology offering.

Innovation for sustainable growth

The research department conducts and participates in projects to provide scientific support for existing technology as well as to create new products—all in an effort to boost the company’s long-term business value. Two of the employees divide their positions between Sectra and Linköping University, where the research is primarily performed in cooperation with the Center for Medical Image Science and Visualization (CMIV). Sectra is currently involved in approximately ten research projects, including projects in the fields of digital pathology and genomics. Previous projects have resulted in improvements and expansions to our product offering.

Progress in data-intensive diagnostics

An overarching theme for the initiatives in the research department is data-intensive diagnostics that support healthcare’s development towards precision medicine. One area Sectra is studying is the decision support that will be needed for the healthcare sector’s diagnostic analyses in genomics, known as variant analysis. Another active area is how the latest AI language models can be used in innovative tools, for example for radiologists.

Sectra also contributes research in diagnostic imaging so that AI can move from the laboratory to clinical reality. Sectra is one of the main participants in the Vinnova-funded project AIDA, which serves as a national arena for research into AI for medical image analysis, with the aim of leveraging the full benefits of AI-based tools in the healthcare sector.

The multiyear EU project Bigpicture is also ongoing within pathology. The project aims to develop the largest-ever database of pathology images to be used for research and innovation in AI. Bigpicture is a part of the Innovative Medicines Initiative program. Sectra’s contribution will accelerate the development of improved diagnostic methods based on AI and support collaborative efforts between healthcare and research.


Gustaf Schwang

General Manager Orthopaedics business unit

Johan Carlegrim

General Manager Medical Education business unit

Fredrik Lysholm

General Manager Genomics IT business unit

Claes Lundström

Research Director Medical systems